Ritonavir [clinicaltrials_resource:29d5ea03a28cc360bd1849812b689a04]
A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells [clinicaltrials:NCT00000822]A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 [clinicaltrials:NCT00000859]Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies [clinicaltrials:NCT00000888]Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315 [clinicaltrials:NCT00000891]A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir [clinicaltrials:NCT00000892]The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir [clinicaltrials:NCT00000898]A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment [clinicaltrials:NCT00000902]Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients [clinicaltrials:NCT00000906]A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children [clinicaltrials:NCT00000913]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [clinicaltrials:NCT00000919]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]A Study to Compare Two Different Anti-HIV Drug Regimens [clinicaltrials:NCT00000924]Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [clinicaltrials:NCT00000940]A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood [clinicaltrials:NCT00000941]A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children [clinicaltrials:NCT00000952]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients [clinicaltrials:NCT00001075]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses [clinicaltrials:NCT00001108]Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [clinicaltrials:NCT00001119]Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [clinicaltrials:NCT00001133]A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine [clinicaltrials:NCT00001688]Once-Daily Drug Regimen for HIV-Infected Patients [clinicaltrials:NCT00001968]A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients [clinicaltrials:NCT00002178]A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients [clinicaltrials:NCT00002201]A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients [clinicaltrials:NCT00002223]A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [clinicaltrials:NCT00002239]Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily [clinicaltrials:NCT00002241]Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors [clinicaltrials:NCT00002361]The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma [clinicaltrials:NCT00002366]A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients [clinicaltrials:NCT00002374]A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients [clinicaltrials:NCT00002378]A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002440]A Study to Compare Two Anti-HIV Drug Combinations [clinicaltrials:NCT00002447]A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients [clinicaltrials:NCT00002448]Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [clinicaltrials:NCT00002451]
intervention [clinicaltrials_vocabulary:intervention]
Ritonavir [clinicaltrials_resource:29d5ea03a28cc360bd1849812b689a04]
Bio2RDF identifier
29d5ea03a28cc360bd1849812b689a04
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:29d5ea03a28cc360bd1849812b689a04
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:29d5ea03a28cc360bd1849812b689a04
title
Ritonavir
@en
type
label
Ritonavir [clinicaltrials_resource:29d5ea03a28cc360bd1849812b689a04]
@en